Thromb Haemost 1985; 53(03): 408-410
DOI: 10.1055/s-0038-1661325
Original Article
Schattauer GmbH Stuttgart

Kinetics of In-111-Platelets in the Baboon: II. In Vivo Distribution and Sites of Sequestration

H F Kotzé
The Platelet Research Unit, South African Medical Research Council, and the University of the Orange Free State, Bloemfontein, South Africa
,
M G Lötter
The Platelet Research Unit, South African Medical Research Council, and the University of the Orange Free State, Bloemfontein, South Africa
,
P N Badenhorst
The Platelet Research Unit, South African Medical Research Council, and the University of the Orange Free State, Bloemfontein, South Africa
,
A du P Heyns
The Platelet Research Unit, South African Medical Research Council, and the University of the Orange Free State, Bloemfontein, South Africa
› Author Affiliations
Further Information

Publication History

Received 04 October 1984

Accepted 22 March 1985

Publication Date:
18 July 2018 (online)

Summary

The kinetics and sites of sequestration of a fully representative population of In-111-platelets were determined in 11 baboons. The in vivo method of quantification with computer assisted scintillation camera image analysis was validated by sacrificing 5 baboons and measuring and comparing the distribution of organ radioactivity. Recovery of platelets in the circulation was 87% ±7, and their mean survival time was 147 hr± 15. The mean splenic platelet pool was 16.0% ± 1.9. At equilibrium 15.8% ± 2.9 of the In-111-platelets were in the hepatic blood pool. Senescent platelets were destroyed in the reticulo-endothelial system. The major sites of sequestration were: liver (37.6% ±6.0), and the spleen (23.3% ±4.6). The bone marrow sequestrated 14.4% ± 1.7 of the labelled platelets, and 15.5% ±4.0 were present in various other tissues. We conclude that the in vivo method of In-111- quantification is accurate. Senescent platelets are mainly sequestrated in the reticuloendothelial tissue, with the liver, spleen and the bone marrow important sites of sequestration.

 
  • References

  • 1 Heyns Adu P, Lötter MG, Badenhorst PN, van Reenen OR, Pieters H, Minnaar PC, Retief FP. Kinetics, distribution and sites of destruction of In-lll-labelled human platelets. Br J Haematol 1980; 44: 269-280
  • 2 Van Reenen O, Lötter MG, Heyns Adu P, De Kock F, Herbst C, Kotzé H, Pieters H, Minnaar PC, Badenhorst PN. Quantification of the distribution of In-lll-labelled platelets in organs. Eur J Nucl Med 1982; 7: 80-84
  • 3 Heyns Adu P, Badenhorst PN, Lotter MG. Platelet imaging. In the Measurement of Platelet Function. Harker LA, Zimmerman TS. (Eds) Churchill Livingstone; Edinburgh: 1983. pp 214-232
  • 4 Badenhorst PN, Lötter MG, Heyns Adu P, Van Reenen OR, Herbst C, Pieters H, Kotzé HF, Duyvené de Witt LJ, Minnaar PC. The influence of the “collection injury” on the survival and distribution of In-lll-labelled canine platelets. Br J Haematol 1982; 52: 233-240
  • 5 Aster RH. Studies of the fate of platelets in rats and man. Blood 1969; 34: 117-127
  • 6 Klonizakis I, Peters AM, Fitzpatrick ML, Kensett MJ, Lewis SM, Lavender JP. Radionuclide distribution following injection of In-lll- labelled platelets. Br J Haematol 1980; 46: 595-609
  • 7 Scheffel U, Tsan M-F, Mitchell TG, Camargo EE, Braine H, Ezekowitz MD, Nicoloff EL, Hill-Zobel R, Murphy E, McIntyre PA. Human platelets labelled with In-lll-8-hydroxyquinoline: Kinetics, distribution and estimates of radiation dose. J Nucl Med 1982; 23: 149-156
  • 8 Lötter MG, Badenhorst PN, Heyns Adu P, Van Reenen OR, Pieters H, Minnaar PC. Kinetics, distribution and sites of destruction of canine blood platelets with In-lll-oxine. J Nucl Med 1980; 21: 36-40
  • 9 Hill-Zobel RL, Scheffel U, McIntyre PA, Tsan M-F. In-lll-oxine labelled rabbit platelets: In vivo distribution and sites of destruction. Blood 1983; 61: 149-153
  • 10 Gresham GA. The use of primates in cardiovascular research. In Nonhuman primates and medical research. Bournes GH. (Ed) Academic Press; New York - London: 1973. pp 255-247
  • 11 Hampton JW, Matthews C. Similarities between baboon and human blood clotting. J Appl Physiol 1965; 21: 1713-1716
  • 12 Kotzé HF, Lötter MG, Badenhorst PN, Heyns Adu P. Isolation and labelling of a viable and representative platelet population. Thromb Haemostas 1985; 53: 404-407
  • 13 Heyns Adu P, Badenhorst PN, Pieters H, Lötter MG, Minnaar PC, Duyvené de Witt LJ, Van Reenen OR, Retief FP. Preparation of a viable population of In-lll-labelled human platelets. Thromb Haemostas 1980; 42: 1473-1482
  • 14 I. C. S. H.. Panel on diagnostic application of radioisotopes in Hematology: Recommended methods for radioisotope platelet survival studies. Blood 1977; 50: 1137-1144
  • 15 Murphy EA, Francis ME. The estimation of blood platelet survival. II. The multiple hit model. Thrombos Diathes Haemorrh 1971; 25: 53-80
  • 16 Harker LA, Hanson SR. Experimental arterial thromboembolism in baboons: Mechanism, quantitation and pharmacological prevention. J Clin Invest 1979; 64: 559-569
  • 17 Hanson SR, Harker LA, Ratner BD, Hoffman SR. In vivo evaluation of artificial surfaces with a non-human primate model of arterial thrombosis. J Lab Clin Med 1980; 95: 289-304
  • 18 Peters AM, Lavender JP. Platelet kinetics with In-111: comparison with Cr-51 platelets. Sem Thromb Haemostas 1983; 9: 100-114
  • 19 Freedman ML, Altzuler N, Karpatkin S. Presence of a non-splenic platelet pool. Blood 1977; 50: 419-425
  • 20 Peters AM, Klonizakis I, Lavender JM, Lewis SM. Elution of Indium-111 from reticuloendothelial cells. J Clin Path 1982; 35: 507-509
  • 21 Hanson SR, Slichter SJ, Harker LA. The platelet requirement for normal hemostasis in man. Thromb Haemostas 1983; 50: 189 (Abstr.)